CVRx Stock

cvrx.comHealthcareFounded: 1900Funding to Date: $384.4MM

CVRx is the developer of a proprietary implantable technology for the treatment of high blood pressure and heart failure

Register for Details

For more details on financing and valuation for CVRx, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

By registering, you agree to the Forge Terms of Use. Already registered? Click here to log in

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for CVRx.

Register Today

Team

Management Team

John Brintnall
Chief Financial Officer
Julia Stubben
Vice President, European Sales & Marketing
Nadim Yared
President, Chief Executive Officer & Board Member
Joseph DuPay
Senior Vice President, Development & Operations
Jared Oasheim
Controller
Dean Bruhn-Ding
Vice President of Regulatory Affairs and Quality Assurance

Board Members

Geoff Pardo
Gilde Healthcare Partners
Ali Behbahani MD
New Enterprise Associates
John Nehra
New Enterprise Associates
Kadir Kadhiresan Ph.D
Johnson & Johnson Innovation - JJDC
Tom Heyman
Johnson & Johnson Innovation - JJDC
Claudia D'Augusta Ph.D
Ysios Capital
Juan-Pablo Mas
Action Potential Venture Capital
Joseph Slattery
Nadim Yared

Other companies like CVRx in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.6B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$150MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$296.3MM
Sector
Last Round Est. Valuation
$4.8B

News

Barostim device gets FDA nod to treat heart failure by stimulating nerve endings in the neck
/PRNewswire/ -- CVRx, Inc., a private medical device company, has secured equity financing totaling $93 million and a new $20 million debt facility. CVRx plans...